Episode 6: J-Pouch Care: Disorders and Complications Episode 6: J-Pouch Care: Disorders and Complications
Pouch expert Dr Laura Raffals joins Dr Sunanda Kane to deep-dive into patient care after J-pouch surgery. Topics include pouchitis, Crohn ' s of the pouch, pelvic floor dysfunction, and pregnancy.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 20, 2023 Category: Consumer Health News Tags: Gastroenterology InDiscussion Source Type: news
Crohn's Disease: What Is It, and How Can It Be Treated?
THURSDAY, June 15, 2023 -- Crohn ' s disease can turn your life into a gastrointestinal nightmare, but there is hope.
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), more than half a million Americans have... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 15, 2023 Category: General Medicine Source Type: news
Crohn Disease More Common in People With Hidradenitis Suppurativa
WEDNESDAY, June 14, 2023 -- Pediatric patients with hidradenitis suppurativa (HS) have a higher prevalence of Crohn disease, according to a research letter published online June 14 in JAMA Dermatology.
Nicole Mastacouris, from the Donald and Barbara... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2023 Category: Pharmaceuticals Source Type: news
Crohn's Associated With HS in Kids, Analysis Suggests Crohn's Associated With HS in Kids, Analysis Suggests
The low absolute prevalence of Crohn ' s disease among pediatric patients with hidradenitis suppurativa"is reassuring," the researchers write.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 14, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Prevalence of IBD in Canada May Increase 37% by 2035 Prevalence of IBD in Canada May Increase 37% by 2035
A report by Crohn ' s Colitis Canada aims to prepare the healthcare system and research community for future challenges linked to the burden of IBD.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 12, 2023 Category: Primary Care Tags: Gastroenterology News Source Type: news
What Are Some High or Low FODMAPs Foods?
Discussion
FODMAPs is an acronym standing for fermentable oligosaccharides, disaccharides, monosaccharides and polyols. It is a diet strategy which has shown improvement for some adult patients with functional abdominal pain including some with irritable bowel syndrome. The evidence in pediatrics is murky and more well-designed studies are needed; however such studies are difficult to complete. In general, there are 3 phases to this dietary strategy:
Avoidance of all high FODMAP foods for 2-6 weeks. In some adult studies there has been improvement in 1 week. Especially in the pediatric age group, some people will only res...
Source: PediatricEducation.org - June 12, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
New England Journal of Medicine publishes results from Phase 3 induction and maintenance programs evaluating upadacitinib (RINVOQ ®) in Crohn & #039;s disease
AbbVie (NYSE: ABBV) announced the New England Journal of Medicine (NEJM) published results from the pivotal Phase 3 clinical trials - U-EXCEL, U-EXCEED and U-ENDURE - evaluating upadacitinib (RINVOQ®) in adult patients with moderately to severely active Crohn's disease who have had an inadequate response, lost response or were intolerant to conventional therapy or a biologic agent. (Source: World Pharma News)
Source: World Pharma News - June 6, 2023 Category: Pharmaceuticals Tags: Featured AbbVie Business and Industry Source Type: news
Doctor: What My Patients Have Taught Me About Crohn ’s
A doctor explains some of the frustrations and problems his Crohn’s disease patients face and how he works to help them. (Source: WebMD Health)
Source: WebMD Health - June 2, 2023 Category: Consumer Health News Source Type: news
Doctors, Researchers Work Hard to Improve Crohn ’s Disease Treatments
Learn how Crohn’s disease treatment and long-term outlook have improved over the past few decades. (Source: WebMD Health)
Source: WebMD Health - June 2, 2023 Category: Consumer Health News Source Type: news
Patient seeks to give back by participating in clinical trials to advance research
Mark Lewis is an advocate for participating in clinical trials. As a person who is immunocompromised and has been a Mayo Clinic patient for decades, he hopes to inspire others to join clinical trials for "the greater good." Lewis has lived with Crohn's disease, a type of inflammatory bowel disease (IBD) marked by inflammation of the lining of the digestive tract, since he was in high school in the mid-1970s. He's struggled with debilitating symptoms. Now, he's… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 2, 2023 Category: Databases & Libraries Source Type: news
Upadacitinib Superior to Placebo in Moderate-to-Severe Crohn Disease
WEDNESDAY, May 31, 2023 -- For patients with moderate-to-severe Crohn disease, upadacitinib induction and maintenance treatment are superior to placebo, according to a study published in the May 25 issue of the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 31, 2023 Category: Pharmaceuticals Source Type: news
Lost Bitcoin
The pseudonymous person or group who created Bitcoin mined 22,000 blocks with a single rig between January 1st, 2009, and January 25th, 2010. Rewards back then were 50 BTC per block. And since then, Nakamoto hasn’t moved a single BTC. We don’t know if Satoshi has access or has deliberately left…#nakamoto #romanian #mirceapopescu #costarica #bitcoin #hackers #silkroad #crohn #netflix #maxkeiser (Source: Reuters: Health)
Source: Reuters: Health - May 30, 2023 Category: Consumer Health News Source Type: news
A Close Look at the Data Backing Upadacitinib's Approval in Crohn's
(MedPage Today) -- The selective Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) improved clinical remission and endoscopic response rates compared with placebo in patients with moderate-to-severe Crohn's disease, according to two induction... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 25, 2023 Category: Gastroenterology Source Type: news
With Moderna windfall, Harvard professor and integrins legend Tim Springer donates $210M to his Institute for Protein Innovation
Tim Springer, with his name stapled to the likes of Moderna, Scholar Rock and Editas Medicine, plus the foundational work for Takeda’s ulcerative colitis and Crohn’s disease med Entyvio, has had a lot on his plate over the past five decades. In 2020, the Harvard professor became a billionaire…#timspringer #moderna #scholarrock #takeda #crohn #harvard #leukosite (Source: Reuters: Health)
Source: Reuters: Health - May 24, 2023 Category: Consumer Health News Source Type: news
Big pharma ’s patent cliff is fast approaching
A of $10.8bn would look hefty for most acquisitions of smallish and newish companies. But for Merck, a drugs giant known as outside America, the money it is spending to buy Prometheus Biosciences, a biotech firm based in California, is relatively small change. In the world of big pharma such deals…#merck #prometheus #crohn #keytruda #pfizer #pharma #seagen #bellushealth #bottomline (Source: Reuters: Health)
Source: Reuters: Health - May 20, 2023 Category: Consumer Health News Source Type: news
